Akums receives DCGI approval for Colchicine 0.5 mg tablets EP News Bureau Sep 29, 2026 First-time-in-India approval strengthens Akums’ presence in the growing cardiovascular therapeutics segment
CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients Press Trust of India Jun 12, 2021 Enrolment of patients has already begun at multiple sites across India and the trial is likely to be completed in the next 8-10…
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against… Press Information Bureau Jul 8, 2020 In collaboration with Laxai Life Sciences, it aims to determine the safety and efficacy of three combination drugs…
